Objectives

After participating in this educational activity, attendees should be able to

1. Identify the clinical and laboratory characteristics of children diagnosed with MIS-C in our institution. 
2. Recognize comorbidities associated with children diagnosed with MIS-C at Baystate Children's Hospital.
3. Acknowledge factors associated with progression to Macrophage activation syndrome (MAS) in children diagnosed with MIS-C.
4. Recognize the mechanism of action and the role of IL-1 receptor antagonists in the management of MAS secondary to MIS-C.
 

Faculty

Ingrid Camelo, MD, MPH*
Pediatric Infectious Disease Specialist
Baystate Children's Hospital

Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.